A popular and widely used antidepressant is being recalled from shelves after failing to meet quality standards, the U.S. Food and Drug Administration (FDA) said.
The agency’s enforcement report said that a large number of already shipped medications have been recalled from all corners of the globe. The recall was issued on March 17, 2026. The event mainly impacted the lot number 8177156. The bottles contain 60 tablets of the 3 mg extended release version of the prescription drug. The expiration date of each medicine is February 28, 2027.
The problem as per FDA, is that the tablets may not break down and release the drug into the patients’ bodies as intended. This could make the medicine ineffective or less effective, experts explained.
Take Control of Your Health Today
Quickly check your symptoms and understand your prescriptions with our smart, easy-to-use AI tools.
According to the Cleveland Clinic, the recall has been categorized as Class II that means the recall might have a temporary impact on the globe. As per an expert, this was done to avert serious health consequences.
For more interesting news and updates on antidepressants and other medicines, follow Medipedia. We help you stay up to date on the latest news and developments in health, medication, and treatment practices.
Disclaimer:
This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting or changing any medication or treatment.